Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 1 |
2025 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
ha do l a[au]
(4 results)?
Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial.
Lancet Reg Health West Pac. 2023 Nov 21;42:100953. doi: 10.1016/j.lanwpc.2023.100953. eCollection 2024 Jan.
Lancet Reg Health West Pac. 2023.
PMID: 38357398
Free PMC article.
Changing Epidemiology of Respiratory Syncytial Virus in Australia-Delayed Re-Emergence in Victoria Compared to Western Australia/New South Wales (WA/NSW) After Prolonged Lock-Down for Coronavirus Disease 2019 (COVID-19).
McNab S, Ha Do LA, Clifford V, Crawford NW, Daley A, Mulholland K, Cheng D, South M, Waller G, Barr I, Wurzel D.
McNab S, et al. Among authors: ha do la.
Clin Infect Dis. 2021 Dec 16;73(12):2365-2366. doi: 10.1093/cid/ciab240.
Clin Infect Dis. 2021.
PMID: 33735388
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.